Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Unlabelled: Behavioral and Psychological Symptoms of Dementia (BPSD) are a heterogeneous set of psychological and behavioral abnormalities seen in persons with dementia (PwD), significantly impacting their quality of life and that of their caregivers. Current assessment tools, such as the Neuropsychiatric Inventory (NPI), are limited by recall bias and lack of direct observation. This study aims to overcome this limitation by making caregiver reports more objective through the use of a novel instrument, referred to as the BPSDiary. This randomized controlled trial will involve 300 caregiver-PwD dyads. The objective is to evaluate whether the use of the BPSDiary could significantly reduce caregiver burden, assessed using the Zarit Burden Interview (ZBI), compared to usual care. The study will include adult PwD, caregivers living with or close to the patient, and BPSD related to the HIDA (hyperactivity, impulsivity, irritability, disinhibition, aggression, agitation) domain. Caregivers randomized to the intervention arm will use the BPSDiary to record specific BPSD, including insomnia, agitation/anxiety, aggression, purposeless motor behavior, and delusions/hallucinations, registering time of onset, severity, and potential triggers. The primary outcome will be the change in ZBI scores at 3 months, with secondary outcomes including changes in NPI scores, olanzapine equivalents, NPI-distress scores related to specific BPSD domains, and caregiver and physician satisfaction. The study will be conducted in 9 Italian centers, representing diverse geographic and sociocultural contexts. While potential limitations include the relatively short observation period and the focus on specific BPSD disturbances, the BPSDiary could provide physicians with objective data to tailor appropriate non-pharmacological and pharmacological interventions. Additionally, it may empower caregivers by encouraging reflection on BPSD triggers, with the potential to improve the quality of life for both PwD and their caregivers.

Trial Registry: NCT05977855.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11285609PMC
http://dx.doi.org/10.3389/frdem.2023.1301280DOI Listing

Publication Analysis

Top Keywords

specific bpsd
12
randomized controlled
8
controlled trial
8
quality life
8
study will
8
bpsd
7
bpsdiary
5
will
5
bpsdiary study
4
study protocol
4

Similar Publications

Introduction: Risperidone is approved for behaviors and psychological symptoms of dementia (BPSD), despite modest efficacy and known risks. Identifying responsive symptoms, treatment modifiers, and predictors is crucial for personalized treatment.

Method: A one-stage individual participant data meta-analysis of six randomized controlled trials (risperidone: n = 1009; placebo: N = 712) was conducted.

View Article and Find Full Text PDF

Background: Behavioural and psychological symptoms of dementia (BPSD), encompassing disturbances in perception, thought, mood and behaviour, are prevalent among individuals with dementia and can substantially affect their quality of life. Although prior research has suggested that hearing impairment (HI) may exacerbate BPSD due to communication difficulties and diminished social engagement, the relationship between HI and specific BPSD manifestations remains insufficiently explored. This study aims to examine the association between HI and distinct BPSD in individuals with cognitive decline attending a memory clinic.

View Article and Find Full Text PDF

Prototype Checklist for Nonpharmacologic Strategies in Nursing Home Dementia Care.

J Am Med Dir Assoc

August 2025

The Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA.

The Centers for Medicare and Medicaid Services recommend that nursing homes use nonpharmacologic approaches as the first-line treatment for behavioral and psychological symptoms of dementia (BPSD). However, nursing homes face significant challenges in implementing nonpharmacologic strategies, from identifying the underlying cause of BPSD to selecting the most appropriate nonpharmacologic strategy. An effective strategy must be aligned with each resident's unique symptoms, capabilities, and preferences, but it must be done with limited staff and resources in a complex care environment.

View Article and Find Full Text PDF

Introduction: Behavioral and psychological symptoms of dementia (BPSD) significantly affect the quality of life for patients with Alzheimer's disease (AD) and contribute to caregiver burden. Although systemic inflammation is implicated in AD pathophysiology, the specific role of peripheral immune activity-particularly interleukin-6 (IL-6)-in relation to BPSD remains unclear, especially regarding its independent effects from central neuroinflammation.

Methods: We conducted a cross-sectional study of 23 biomarker-confirmed patients diagnosed with AD or prodromal AD.

View Article and Find Full Text PDF

Background: Caregivers caring for patients with dementia could experience depressive symptoms, distress from patients' behavioral symptoms, and physical morbidities. Factors associated with a caregiving burden are complex and vary with time because burden is a subjective measure influenced by physical, economic, and psychosocial strain and has an interaction among caregiver resources, vulnerabilities, and care demands. The purpose of this study was to elucidate the association of patients' and caregivers' factors especially the severity of behavior and psychiatric symptoms of dementia (BPSD) and specific activities of daily living items impairment with a moderate or even severe caregiving burden.

View Article and Find Full Text PDF